Bank of New York Mellon’s Ocera Therapeutics, Inc. OCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-31,880
| Closed | -$37K | – | 4429 |
|
|
2017
Q3 | $37K | Sell |
31,880
-5,143
| -14% | -$5.97K | ﹤0.01% | 4153 |
|
|
2017
Q2 | $43K | Buy |
37,023
+1,515
| +4% | +$1.76K | ﹤0.01% | 4151 |
|
|
2017
Q1 | $46K | Buy |
35,508
+3,628
| +11% | +$4.7K | ﹤0.01% | 4144 |
|
|
2016
Q4 | $67K | Sell |
31,880
-584
| -2% | -$1.23K | ﹤0.01% | 4087 |
|
|
2016
Q3 | $85K | Sell |
32,464
-1,672
| -5% | -$4.38K | ﹤0.01% | 4075 |
|
|
2016
Q2 | $65K | Sell |
34,136
-3,774
| -10% | -$7.19K | ﹤0.01% | 4132 |
|
|
2016
Q1 | $112K | Hold |
37,910
| – | – | ﹤0.01% | 3942 |
|
|
2015
Q4 | $119K | Buy |
37,910
+3,774
| +11% | +$11.8K | ﹤0.01% | 3991 |
|
|
2015
Q3 | $108K | Hold |
34,136
| – | – | ﹤0.01% | 4041 |
|
|
2015
Q2 | $129K | Sell |
34,136
-983
| -3% | -$3.72K | ﹤0.01% | 3988 |
|
|
2015
Q1 | $165K | Buy |
35,119
+9,823
| +39% | +$46.2K | ﹤0.01% | 3942 |
|
|
2014
Q4 | $161K | Buy |
25,296
+3,593
| +17% | +$22.9K | ﹤0.01% | 3937 |
|
|
2014
Q3 | $106K | Hold |
21,703
| – | – | ﹤0.01% | 4030 |
|
|
2014
Q2 | $166K | Hold |
21,703
| – | – | ﹤0.01% | 3881 |
|
|
2014
Q1 | $229K | Buy |
+21,703
| New | +$229K | ﹤0.01% | 3797 |
|